Ti Li Loo
Impact in
Papers in
- Biochemistry 12
- Amino Acid Enzymes and Metabolism 10
- Pharmacology 11
- Pharmacogenetics and Drug Metabolism 7
- Co-authors
- Katherine LuRobert S. BenjaminJohn A. BenvenutoRobert L. DionNiramol SavarajDavid J. StewartDavid FarquharMario A. Luna
- Journals
- Biochemical Pharmacology (9 papers)Journal of Medicinal Chemistry (8 papers)Cancer Chemotherapy and Pharmacology (7 papers)Journal of Pharmaceutical Sciences (6 papers)Journal of Neuro-Oncology (5 papers)
- Partner nations
- United StatesCanadaIndia
In The Last Decade
Ti Li Loo
103 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 129
- Oncology 699
- Genetics 264
- Pharmacology 208
- Physiology 94
- Pharmaceutical Science 88
Countries citing papers authored by Ti Li Loo
This map shows the geographic impact of Ti Li Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ti Li Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ti Li Loo more than expected).
Fields of papers citing papers by Ti Li Loo
This network shows the impact of papers produced by Ti Li Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ti Li Loo. The network helps show where Ti Li Loo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ti Li Loo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 26 | |
| 2 | Induction of DNA strand breaks and cross-links by 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone in Chinese hamster ovary cells. | 1984 | 20 |
| 3 | 1984 | 6 | |
| 4 | 1982 | 54 | |
| 5 | Comparative structure-genotoxicity study of three aminoanthraquinone drugs and doxorubicin. | 1981 | 43 |
| 6 | 1980 | 163 | |
| 7 | 1979 | 6 | |
| 8 | Human urinary metabolites of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftoraful). | 1979 | 7 |
| 9 | 1978 | 11 | |
| 10 | 1978 | 24 | |
| 11 | 1975 | 13 | |
| 12 | Schedule-dependent synergistic cytotoxicity of arabinofuranosylcytosine with adriamycin or 3,6-bis(5-chloro-2-piperidinyl)-2,5-piperazinedione in cultured cells. | 1975 | 9 |
| 13 | 1972 | 38 | |
| 14 | 1972 | 21 | |
| 15 | 1971 | 19 | |
| 16 | 1968 | 31 | |
| 17 | 1967 | 63 | |
| 18 | 1965 | 16 | |
| 19 | 1961 | 6 | |
| 20 | 1958 | 8 |
About Ti Li Loo
Ti Li Loo is a scholar working on Biochemistry, Pharmacology, Toxicology, Genetics and Clinical Biochemistry, having authored 103 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (13 papers), Biochemical and Molecular Research (12 papers), Amino Acid Enzymes and Metabolism (10 papers), Drug Transport and Resistance Mechanisms (9 papers), Cancer Treatment and Pharmacology (9 papers), Synthesis and Biological Evaluation (8 papers), Glioma Diagnosis and Treatment (7 papers) and Pharmacogenetics and Drug Metabolism (7 papers). The work is most often cited by research in Oncology (699 citations), Genetics (264 citations), Pharmacology (208 citations), Physiology (94 citations) and Pharmaceutical Science (88 citations). Ti Li Loo has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Katherine Lu, Robert S. Benjamin, John A. Benvenuto, Robert L. Dion, Niramol Savaraj, David J. Stewart, David Farquhar, Mario A. Luna, David G. Johns and Milam E. Leavens. Their work appears in journals such as Biochemical Pharmacology, Journal of Medicinal Chemistry, Cancer Chemotherapy and Pharmacology, Journal of Pharmaceutical Sciences and Journal of Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.